TGFBI and neoplasm: To assess whether BIGH3 plays a role of tumor suppressor or promoter in the retina, a cohort of SV40-TAg (n=85) and SV40-TAg/Bigh3−/− (n=59) was generated and tumor development was studied for up to 6 months.